Drug class
Vasoprotective agent; capillary-stabilising naphthoquinone derivative
Mechanism of action
Proposed to reduce capillary permeability and fragility and improve microcirculatory function. The exact molecular mechanism and strength of clinical evidence are not fully established.
General use cases
- Symptomatic treatment of chronic venous insufficiency and capillary fragility in countries where aminaphtone products are authorised; use should follow current national product information
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
